148 related articles for article (PubMed ID: 8546598)
1. [The effect of urapidil on blood pressure, renal hemodynamics, lipid and glucose metabolism].
Sanjuliani AF; Fagundes VG; Francischetti EA
Arq Bras Cardiol; 1995 Jul; 65(1):59-63. PubMed ID: 8546598
[TBL] [Abstract][Full Text] [Related]
2. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
3. Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
De Lima MD; Kohlmann NE; Neves FA; Zanella MT; Ribeiro AB; Kohlmann O
Blood Press Suppl; 1994; 4():53-6. PubMed ID: 7804514
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
5. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
6. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function].
Wambach G; Godehardt E; Lang R; Haerlin R; Meurer KA
Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
Oren S; Turkot S; Paran E; Flandra O; Slezak L; Hof B
J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
[TBL] [Abstract][Full Text] [Related]
8. [Circulatory changes with urapidil (Ebrantil) in general and regional anesthesia. Studies with normo- and hypertensive patients].
Lehmann KA; Heimig T
Anaesthesist; 1985 Sep; 34(9):435-45. PubMed ID: 4083465
[TBL] [Abstract][Full Text] [Related]
9. Urapidil in hypercholesterolemic hypertensive patients.
Ferrara LA; Leonetti G; Fogari R; Mazzola C; Mancini M; Zanchetti A
Blood Press Suppl; 1994; 4():39-44. PubMed ID: 7804511
[TBL] [Abstract][Full Text] [Related]
10. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
Amodeo C; Barros LM; Batlouni M; Sousa JE
Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
[TBL] [Abstract][Full Text] [Related]
11. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A
Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313
[TBL] [Abstract][Full Text] [Related]
12. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].
Li S; Feng H; Zhu J; Zhong C; Leng X; Du R
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):287-90. PubMed ID: 12828169
[TBL] [Abstract][Full Text] [Related]
13. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of systemic arterial hypertension with urapidil. Study in mild and moderate hypertension with ambulatory monitoring of arterial pressure].
Nobre F; Nogueira JL
Arq Bras Cardiol; 1993 Jul; 61(1):63-8. PubMed ID: 8285870
[TBL] [Abstract][Full Text] [Related]
15. Cardiac and circulatory response to the intravenous administration of urapidil during general anaesthesia.
Fontana F; Allaria B; Brunetti B; Arienta R; Favaro M; Trivellato A; Rusconi MG
Drugs Exp Clin Res; 1990; 16(6):315-8. PubMed ID: 2086167
[TBL] [Abstract][Full Text] [Related]
16. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
Fagerberg B; Berglund A; Andersson OK; Berglund G
J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
[TBL] [Abstract][Full Text] [Related]
18. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
Hermida RC; Ayala DE; Khder Y; Calvo C
Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
[TBL] [Abstract][Full Text] [Related]
19. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients.
Kanbay M; Yildirir A; Bozbas H; Ulus T; Bilgi M; Muderrisoglu H; Akcay A; Ozdemir FN
Ren Fail; 2005; 27(3):297-303. PubMed ID: 15957546
[TBL] [Abstract][Full Text] [Related]
20. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
Haenni A; Lithell H
J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
